13 / 25
PCOS 2018
Journal of Clinical and Molecular Endocrinology
ISSN: 2572-5432
Page 41
June 07-08, 2018
London, UK
4
th
World Congress on
Polycystic Ovarian
Syndrome
P
olycystic ovary syndrome (PCOS) is a prevalent, and yet a
poorly understood disorder that constitutes the commonest
endocrinopathy of reproductive years. There exists heterogeneity
in the clinical presentation, and pathophysiological underpinnings
are varied. Insulin resistance is recognized as a contributor
to the endocrine and metabolic milieu of PCOS. Management
strategies are individualized to address the symptom burden,
as well as to harness the covert risks that are well recognized in
this this population. A small repertoire of natural supplements
and vitamins has been examined for therapeutic potential in
PCOS populations, with some promising results. Existing data on
therapeutic benefits of vitamin D as well as certain nutraceuticals
which will be shared in this presentation.
lubna.pal@yale.eduPlace of vitamins and nutraceuticals in PCOS management?
Lubna Pal
Yale School of Medicine, USA
J Clin Mol Endocrinol 2018, Volume 3
DOI: 10.21767/2572-5432-C1-003